Abbott India Share Price

ABOUT Abbott India

• Industry Biotechnology & Drugs
• ISIN INE358A01014
• BSE Code 500488
• NSE Code ABBOTINDIA

Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.

MANAGEMENT

• Sridhar Kadangode Chief Financial Officer
• Sangeeta Shetty Chief Compliance Officer, Company Secretary
• Swati Dalal Managing Director, Additional Director
• Kunal Chowdhury Commercial Director - GI Business
• Rajan Kalantre Director - Business Human Resources
• Jejoe Karankumar Director - Medical Affairs
• Murari Ranganathan Commercial Director - Womens Health, Metabolics and International Business
• Ashok Saini Commercial Director - GenNext, Vaccine and Neurolife
• Namita Shah Associate Director - New Product Introductions and Therapy Area Strategy
• Richa Tripathi Associate Director - Sales Force Effectiveness, Project Management Officer